Philadelphia College of Osteopathic Medicine

DigitalCommons@PCOM
PCOM Physician Assistant Studies Student
Scholarship

Student Dissertations, Theses and Papers

2020

Is Cognitive Behavioral Therapy Effective in Alleviating IBS-related
Symptoms Experienced by Patients with Irritable Bowel
Syndrome?
Nathan J. Ambrose
Philadelphia College of Osteopathic Medicine

Follow this and additional works at: https://digitalcommons.pcom.edu/pa_systematic_reviews
Part of the Medicine and Health Sciences Commons

Recommended Citation
Ambrose, Nathan J., "Is Cognitive Behavioral Therapy Effective in Alleviating IBS-related Symptoms
Experienced by Patients with Irritable Bowel Syndrome?" (2020). PCOM Physician Assistant Studies
Student Scholarship. 573.
https://digitalcommons.pcom.edu/pa_systematic_reviews/573

This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student
Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM
Physician Assistant Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For
more information, please contact library@pcom.edu.

Is cognitive behavioral therapy effective in alleviating IBS-related
symptoms experienced by patients with irritable bowel syndrome?

Nathan J Ambrose, PA-S
A SELECTIVE EVIDENCE BASED MEDICINE REVIEW
In Partial Fulfillment of the Requirements For
The Degree of Master of Science
In
Health Sciences – Physician Assistant
Department of Physician Assistant Studies
Philadelphia College of Osteopathic Medicine
Suwanee, Georgia

December 13th, 2019

ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not
cognitive behavioral therapy is effective in alleviating IBS-related symptoms experienced by
patients with irritable bowel syndrome.
STUDY DESIGN: A systematic review of three randomized controlled trials (RCTs) that were
published in peer-reviewed journals in 2009, 2010, and 2018, all in the English language.
DATA SOURCES: All three studies discussed in this systematic review were found and
accessed using PubMed.
OUTCOME MEASURED: Reduction of IBS symptoms as measured by the IBS-SSS
questionnaire and the IBS symptom score analysis.
RESULTS: All three studies yielded a statistically significant reduction (p<.05) in IBS
symptoms through sessions of cognitive behavioral therapy.
CONCLUSIONS: CBT is an effective treatment option that can reduce anxiety and internal
conflict, which may be a contributory or causative agent in IBS patients. The evidence presented
within each of the three studies analyzed in this review suggests that cognitive behavioral
therapy is an effective intervention to alleviate discomfort in patients with irritable bowel
syndrome.
KEY WORDS: Cognitive therapy, CBT, cognitive behavioral therapy, cognitive behavioural
therapy, behavioral therapy, behavioural therapy, irritable bowel syndrome, IBS
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INTRODUCTION
Irritable bowel syndrome (IBS) is a common condition that affects the large intestine.
The typical patient may experience symptoms such as abdominal pain, nausea, flatus, diarrhea,
and/or constipation. Patients with this disorder may experience some or all of these symptoms,
with severity ranging from mild to debilitating. This disorder is more common amongst females,
and affects approximately 25-45 million people in the United States.1 Additionally, IBS is known
to affect the younger population more significantly, and may be influenced by genetics and
environmental disposition. It is estimated that there are 3.5 million healthcare visits annually
attributable to IBS.2 Therefore, providers of all specialties will likely encounter IBS at some
point within their careers. The workup for this diagnosis can be quite extensive, as there is no
specific test for IBS, and thus it is a diagnosis of exclusion. A typical GI workup for IBS will
include obtaining a complete history and physical exam, stool testing, gluten intolerance testing,
flexible sigmoidoscopy or colonoscopy, x-ray or CT scanning. Due to this extensive testing, the
cost associated with IBS medications and indirect costs have been estimated at 21 billion dollars
annually in the United States alone.3 After a provider rules out other potential diagnoses such as
ulcerative colitis, crohns disease, bowel obstruction, or other potentially serious conditions, a
diagnosis of IBS may be appropriate.
There is much yet to learn about this diagnosis. For example, the exact pathophysiology
of this common disorder has perplexed researchers for centuries. The reason for this is in part
due to the complex physiology associated with the enteric nervous system, and how it may be
influenced by external factors such as emotion, diet, and genetics. Furthermore, the gut
microbiota of an individual is responsible for producing a variety of neuroactive molecules,
which communicate with the brain to execute physiologic functions. This communication
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between the gut and the brain is bidirectional. The brain affects the gut primarily through the
central nervous system and endocrine system. Consequentially, the gut is significantly affected
by factors that impact the brain, and dynamics within the brain. Therefore, ones mental health
may have a profound degree of influence on their guts functioning.
Gastrointestinal disturbances are a common complaint amongst patients experiencing
increased levels of anxiety. The specific cause remains unknown, but it may be due in part to the
fact that this population has a colon that is hypersensitive to stress. Research has shown that 50
to 90 percent of IBS patients who seek treatment have a comorbid psychiatric condition such as
anxiety or depression.4 Therefore, mental health conditions may predispose one to an increased
chance of developing irritable bowel syndrome. Conversely, IBS may also increase anxiety or
depression, as it can significantly impair ones daily activities and overall quality of life.
There currently is no cure for this disorder, but there are a number of ways one can
manage this condition. Perhaps the most obvious and initial treatment one should employ, is
avoidance of the dietary factors that are known to cause one distress. Additionally, other lifestyle
changes such as a high fiber diet, adequate hydration, a regular exercise schedule, as well as a
healthy sleep schedule can contribute to the reduction of symptoms.5 As far as pharmalogical
treatment of IBS is concerned, there are a number of different options available. The most
appropriate treatment will correlate with the specific symptoms and severity that one is
experiencing. These classes of medications include laxatives, anticholinergic medications,
tricyclic antidepressants, SSRI antidepressants, pain medications, Alosetron, Eluxadoline,
Rifaximin, Lubiprostone and Linactolide.5 Researchers continue to work tirelessly to develop
new medications to combat this syndrome. For instance, researchers speculate that future
treatments may involve serum-derived bovine immunoglobulin/protein isolate (SBI) and enteric
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coated peppermint oil for successful treatment of diarrhea in certain patients with IBS.5
Psychological interventions such as cognitive behavioral therapy, mindfulness exercises,
hypnosis, and various forms of relaxation therapy may also be of benefit in the treatment of IBS.
The primary focus of these interventions is to utilize the mind as a tool to reduce the negative
effects that the brain produces on the gut. Cognitive behavioral therapy is a specific type of
psychotherapy a therapist can employ to help a patient manage negative thinking or emotional
challenges in a more constructive way. This can ultimately reduce anxiety by teaching one
effective methods to manage their personal stressors. This paper serves to evaluate three
randomized controlled trials (RCTs) to evaluate the potential efficacy of CBT in IBS patients.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not cognitive
behavioral therapy is effective in alleviating IBS-related symptoms experienced by patients with
irritable bowel syndrome.
METHODS
Three RCTs were chosen based on their relevance and ability to answer the objective.
The first RCT completed by Moss-Morris et al. investigates patients meeting Rome I and Rome
II criteria between the ages of 18-72 who can read and write English.6 The intervention applied
to the participants in this study was a seven week manualized program of CBT that is selfadministered in conjunction with a one hour face to face therapy session, and two one hour
phone sessions.6 These patients were compared to a control group of treatment as usual patients
with IBS.6 The outcome that was measured in this study is IBS symptom relief as measured by
the irritable bowel syndrome severity scoring system questionnaire or IBS-SSS.6
The second study done by Jarrett et al. is a three-arm randomized controlled trial, which
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studied adults with IBS recruited through community advertisement.7 The intervention applied to
this population is CBT through nine weekly in-person comprehensive self-management
sessions.7 This population was compared to a control group of IBS patients that were receiving
their usual care.7 The outcome measured in this study is the IBS symptom score, which consists
of 26 IBS symptoms, that were rated on a scale of 0-4.7
The third study done by Lackner et al. is a randomized controlled parallel group trial
studying individuals 18-70 years of age whom are diagnosed with Rome III criteria IBS who
receive CBT.8 The intervention specifically is a group receiving standard-CBT with ten weekly
sixty-minute sessions.8 They were compared against a control group of patients with IBS that
received four information sessions about IBS and the role of lifestyle factors.8 The outcome of
this study was measured by the irritable bowel syndrome symptom severity scale, or IBS-SSS.8
Each of the three articles chosen for this systematic review were personally discovered,
and accessed from the PubMed database. They were all published within the last ten years, in
English, and within peer-reviewed journals.6,7,8 They were discovered by searching the following
keywords: “Cognitive therapy, CBT, Cognitive behavioral therapy, cognitive behavioural
therapy, behavioral therapy, behavioural therapy, irritable bowel syndrome, IBS.” The articles
were selected upon their relevance and ability to answer my proposed clinical question. The
inclusion criteria used for my search consisted of studies published after 2009, randomized
controlled trials, human study participants, and outcomes presented as patient oriented evidence
that matters. The exclusion criteria used for my search consisted of animal study participants,
and studies published earlier than 2009. The three studies all present non-dichotomous data, and
the following statistics were reported and analyzed to make assumptions of treatment efficacy:
mean change from baseline, p-values, CI’s and OR’s.
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Table 1- Demographics & characteristics of included studies
Study

MossMorris6,
2010

Jarrett7,
2009

Lackner8,
2018

Type

Randomized
controlled
trial

Three-arm
randomized
controlled
trial

Randomized
controlled
parallel
group trial

Number
of
patients

64

188

436

Age
(years)

18-72

≥18

18-70

Inclusion
Criteria

Primary care
patients
between the
ages of 18-72
meeting Rome
criteria for IBS.
Must be able to
read and write
English. Must
live in
geographic
proximity of the
study centre.
Participants
must be18 or
older, have a
previous
diagnosis of IBS
made by a
healthcare
provider.
Additionally,
they must have
current IBS
symptoms per
Rome criteria.
Participants
must be
between 18-70
years of age and
suffering from
IBS Rome III
criteria. These
patients must
have moderately
severe
symptoms
occurring at
least twice
weekly and
causing some
life interference.

Exclusion Criteria
W/D

Patients were excluded if
they have a comorbid
illness that could affect
their symptoms. Also, if
they had bowel surgery,
or a current mental
disorder such as a
psychotic disorder or
substance abuse disorder.

Patients were excluded
they had a history of GI,
renal, or reproductive
pathology. They were also
excluded if they had GI
surgery, or took
medications or had
comorbidities that could
be potentially
confounding to the study.

Patients were excluded
from the study if they had
other primary GI disease
or malignancy (other than
skin cancer). Also, if they
had received IBS-targeted
psychotherapy, could not
commit to follow up, had
an unstable extra
intestinal condition, major
psychiatric disorder,
current GI infection, or
used a gut sensitive
antibiotic 12 weeks before
the assessment.

1

12

The study
reports a
9%
attrition
rate
amongst
436
participants. This
correlates
to ~40
people
dropping
from the
study.

Interventions

7-week
manualized
program of
CBT that is
selfadministered
with an one
hour face to
face therapy
session and two
one hour phone
sessions.

9-week
comprehensive
self management
course of
cognitive
behavioral
therapy.

10-week
standard
cognitive
behavioral
therapy for 10
weekly 60
minute
sessions.
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OUTCOMES MEASURED
The outcome of interest in each of the three studies is reported as patient oriented
evidence that matters (POEM). Many different outcomes were assessed throughout each of the
three studies. However, the primary focus of this review will be on IBS symptom reduction
reported through questionnaires. The study by Moss-Morris et al. utilized the IBS-SSS and had
patients return questionnaires at baseline, end of treatment, three months post-treatment, and six
months post-treatment. The study by Jarrett et al. utilized the IBS symptom score questionnaire
at baseline, three months post treatment, six months post-treatment, and twelve months posttreatment. The study by Lackner et al. measured the outcome through the IBS-SSS at baseline,
three months post treatment, and six months post-treatment.
RESULTS
The three studies analyzed in this systematic review present continuous data that is
unable to be converted to dichotomous data. Though the RCTs are all focused on reduction of
IBS symptoms through CBT, the experimental designs are slightly different in each study.
Additionally, the data is analyzed with a variety of differing statistical analyses throughout each
of the studies. The mean change from baseline in regard to symptomatic reduction in IBS
symptom severity is the primary statistic utilized to report the data amongst the three studies.
The study conducted by Moss-Morris et al. was a randomized controlled trial with a
relatively small number of participants, which consisted of IBS patients who had presented to a
primary care office or general practitioner (n=64). The small sample size allowed strict
monitoring of compliance to therapy. This was done by accounting for patient attendance and
compliance with completing their questionnaires. Over 80% of the population at every point
throughout this study attended their CBT therapy sessions, and completed the required
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questionnaires. The results of this study reveal significantly lower severity of IBS symptoms
occurred in the patients who received CBT, in comparison with the treatment as usual (TAU)
group. Interestingly, these patients showed marked improvement immediately at the end of the
study, and continued to improve at three and six months post-treatment. As depicted in Table 2
below, the mean change from baseline in the patient population receiving CBT was 109 points
on the IBS-SSS, compared to 29.5 in the TAU group, when measured at six months post
treatment. The study notes that a 50-point change on the IBS-SSS is clinically significant. 83%
of the population receiving CBT had a clinically significant reduction in their symptoms at six
months post treatment.6 Additionally, 49% of the population receiving TAU reported clinically
significant reduction in their symptoms at six months post-treatment.6 Only four participants
within the experimental group reported that the intervention was not very effective, and no
members reported the treatment as ineffective.6 All in all, this study reports an odds ratio of 12.2
with an associated 95% confidence interval of 3.72-40.1.6 This odds ratio suggests a very strong
likelihood that CBT as a treatment intervention leads to symptomatic reduction in patients with
IBS.
Table 2- IBS symptom evaluation through the IBS-SSS questionnaire amongst patients receiving
CBT versus TAU.
Baseline

End of treatment

3 Months PostTreatment

6 Months PostTreatment

CBT

228.5

156.7

135.4

119.4

TAU

222.8

195.0

190.5

193.3

The study done by Jarrett et al. was a three-arm randomized controlled trial that had a
slightly larger number of subjects, consisting of IBS patients recruited through community
advertisement (n=188). Though the reports were analyzed on a slightly different scale than the
other studies previously discussed, the results of this study were similar. A significant reduction
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of IBS symptoms as measured by the IBS symptom score questionnaire was noted at 3 months, 6
months, and 12 months. These results are further delineated below in Table 3. At 6 months after
treatment initiation, patients receiving CBT reported a 26.6 decrease in their IBS symptom score
questionnaire, compared with a 10.3 decrease in the usual care population.7 Odds ratio
throughout the statistics within this study’s analyses were all large (i.e., greater than 2.3).7 The
patients within this study also reported a significant increase in their work productivity. The
study reports a p-value less than .001 in regard to the IBS symptom score reduction, and
improvement of quality of life amongst the patients receiving CBT.7 The 95% confidence
interval reported within this study at 6 months after the initiation of treatment for group receiving
CBT is -21 to -32, while the usual care group had a 95% confidence interval of -3 to -16.7
Interestingly, this study applied further analysis of IBS symptomatic reduction by logging
recordings of the change from baseline in a variety of specific symptoms that patients were
experiencing. The study yielded results that suggest the largest symptomatic reduction was in
abdominal pain and intestinal gas.7 Thirty-seven percent of patients receiving CBT in this study
reported greater than 50% improvement in their abdominal pain/discomfort.7 Additionally, these
patients reported significant increases in their quality of life and less absence from work due to
their illness after receiving CBT for at least three months. Compliance to therapy and the
assigned homework questionnaires were monitored throughout the study. Eighty-seven percent
of subjects received at least seven of nine sessions, and 91% of patients met the expectations for
the amount of homework that was to be completed.7
Table 3- IBS symptom evaluation through the IBS symptom score questionnaire amongst
patients receiving CBT or usual care.
Baseline

3 Months

6 Months

12 Months

CBT

76

-28.5

-26.6

-25.6

Usual Care

64.9

-5.4

-10.3

-9.5
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The study performed by Lackner et al. was a randomized controlled parallel group trial
consisting of a larger sample size (n=436). Of these participants 9% dropped out from the study
due to varying demographic, psychological, and IBS–related variables.8 This study also showed
significant reduction in the symptoms of IBS with standard CBT. However, the control group in
this study showed a significant reduction in symptoms as well. The study notes that CBT
outperformed IBS education on the IBS-SSS and overall symptomatic improvement but failed to
produce any significant between group difference.8 At six months after the initiation of treatment
the standard CBT group reported a -103.5 +/- 17 point decrease on their IBS-SSS questionnaire,
compared to a 97.93 +/- 15.4 point decrease in the IBS education only sample.8 All changes from
baseline reported below in Table 4 are significant (p<.01). Eighty-nine percent of the participants
within this study were compliant with the treatment regimen, as indicated by attending at least
eight of the ten CBT sessions.8
Table 4- IBS symptom evaluation through the IBS-SSS questionnaire amongst patients receiving
CBT or IBS education alone.
Immediate Post Treatment

3 Months Post Treatment

6 Months Post Treatment

CBT

-80.99 +/- 17.0

-103.2 +/-16.4

-103.5 +/- 17.7

IBS Education Only

-84.43 +/- 14.6

-88.53 +/- 14.6

-97.93 +/- 15.4

DISCUSSION
In summary, CBT is an effective treatment option for an array of mental health illnesses,
as well as IBS. The results from all studies within this review show irrefutable evidence that
CBT is a great treatment option to reduce the symptoms associated with IBS. Though CBT is a
safe form of treatment with no black box warnings or long-term side effects, it may not be
appropriate for every patient. For instance, individuals who have limited intellectual functioning
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or cognitive impairment may not receive benefit from CBT as an intervention.9 One finding
throughout these studies that raises concern over the true effect of CBT can be found within the
Lackner et al study. The control group, which is patients receiving IBS education only, produced
comparable findings to the CBT population. This suggests that a phenomenon other than CBT
may be the causative agent in reducing one’s symptoms. Throughout the three studies, patients
showed continued symptomatic improvement at six months, and in two of the studies, even at
one year. Therefore, CBT can help patients learn skills to independently manage their conditions
appropriately to some degree. A potential drawback from CBT is that the cost may not be
accessible to those without insurance. Approximately 27.6 million people under the age of 65 are
uninsured and may be unable to afford this treatment option.10 Home therapy, or a cheaper
alternative to treatment delivery may reduce this limitation.
Each of the three studies presents limitations that need to be accounted for when making
analyses. For instance, all of these studies focused on CBT in the adult population. More
research needs to be conducted to determine effectiveness of CBT in regards to treating the
pediatric IBS population. In the study by Moss-Morris et al., the majority of participants had
severe IBS symptoms and were less disabled, and depressed than cohorts of comparable studies.6
A lower baseline level of anxiety or depression amongst study participants is a large potential
confounding variable. Within the study by Jarrett et al., the majority of participants were
educated Caucasian females.7 The final study by Lackner et al. relied upon mostly volunteers,
which coincidentally were comprised of mostly women as well.8 Perhaps the biggest drawback
within this study as aforementioned, was that the control group produced similar results to the
treatment population. This leads one to consider if CBT is truly the agent that is reducing IBS
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symptoms. This study suggests that education alone may lead to significant improvement of their
condition, without receiving any form of CBT.
CONCLUSION
In conclusion, CBT is a great option for those with insurance, and ample free time, as a
means of treatment for IBS. Each study produced statistically significant results, which clearly
answers the question of whether or not IBS can be effectively treated with CBT. Further studies
need to be conducted that account for the limitations mentioned within this review. Gender
differences, as well as a patients’ baseline anxiety levels and other mental health illnesses, must
be accounted for to appropriately establish the impact that CBT has on a cohort. The longevity of
symptomatic relief that CBT can provide for these patients is a potential area of research to be
expounded upon. Additionally, future studies can address the cost effectiveness of IBS treatment,
as Americans have one of the highest rates of underinsured or uninsured individuals. It is well
known that CBT can effectively help those with mental health illnesses. However, a future area
of research could focus on how CBT affects those with IBS that have very low baseline levels of
anxiety or other mental health issues. All in all, these studies have done an excellent job in
portraying the many benefits which cognitive behavioral therapy can provide for those suffering
from IBS.
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